AZIFUL^®

Azithromycin is an azalide, a subclass of macrolide antibiotics.

Azithromycin is one of the world's best-selling antibiotics, and is derived from erythromycin; however, it differs chemically from erythromycin in that a methyl-substituted nitrogen atom is incorporated into the lactone ring, thus making the lactone ring 15-membered.

Azithromycin is used to treat or prevent certain bacterial infections, most often those causing middle ear infections, tonsillitis, throat infections, laryngitis, bronchitis, pneumonia, Typhoid, and sinusitis. In recent years it has primarily been used to prevent bacterial infections in infants and those with weaker immune systems. It is also effective against certain urinary tract infections, such as non-gonococcal urethritis and cervicitis. Recent studies have also indicated it to be effective against late-onset asthma, but these findings are controversial and not widely accepted.

Dosage
Skin and soft tissue infections , Respiratory tract infections
Adult: 500 mg once daily for 3 days.

Uncomplicated genital infections due to Chlamydia trachomatis
Adult: 1 g as a single dose.

FULBID^™-500

It is a fluoroquinolone antimicrobial agent with potent activity against a broad spectrum of gram-positive&gram-negative bacteria including Ps. acruginosa, Enterobacteriaceae and Staph aureus. Ciprofloxacin does not disturb normal anaerobic intestinal flora and, has significant post-antibiotic effect & thus prevents regrowth of bacteria. Its antibacterial spectrum is wider than that of aminoglycosides, third generation cephalosporins and other fluoroquinolones.

Indications
Respiratory tract, Urinary tract, E.N.T., skin and soft tissue, Gastro intestinal tract, Intra- abdominal Gynaecological. Bone and joint and Severe systemic infections, Gonorrhoea. Ciprofloxacin 400 mg/200 ml IV infusion 12 hourly is indicated for systemic infection, lower respiratory tract infections, skin and skin structure infections, typhoid fever, severe/complicated urinary tract infections, surgical procedure.

FULCEF^™-200 DT (Cefixime)

Cefixime is an oral third generation cephalosporin antibiotic.
Pharmacokinetics
Cefixime binds to one or more of the penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death.

FULCEF^™-O

Therapeutic Indications & Usage :
FULCEF-O is indicated for multidrug resistant typhoid, Urinary tract infections & pyrexia of unknown origin (PUO). Dosage
1 tablet twice a day for 5 - 7 days or as directed by the Physician
Presentation
FULCEF-O – Strip of 10 tablets.